Master regulator of cell cycle and its role in cancer miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Salvage therapies appeared to maintain clinical activity among patients with relapsed/refractory multiple myeloma who relapsed after B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy, according to study results.The findings, published in Blood, serve as a benchmark for future clinical trials that aim to improve outcomes among patients who experience disease progression
Researchers from Memorial Sloan Kettering Cancer Center (MSK) and Mount Sinai have uncovered treatments that can assist patients with multiple myeloma, a blood cancer, who have tried the immunotherapy CAR-T but have experienced relapses.